GLSI- Greenwich Lifesciences, Inc.
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 4 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.60M | $127.89M | - |
Activity
Buys and sells only
Transactions
4 filings · page 12
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2020 | Hallock Kenneth | Director | Buy | 74,782 | $5.75 | $429,996.50 | +41.0% | |
| Sep 29, 2020 | Patel Snehal | CEO And CFO | Buy | 114,347 | $5.75 | $657,495.25 | +15.3% | |
| Sep 29, 2020 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1,739 | $5.75 | $9,999.25 | +2.1% | |
| Sep 29, 2020 | Patel Snehal | CEO And CFO | Buy | 16,667 | $4.60 | $76,709.87 | +1.4% |
← PrevPage 12